September 26, 2017 at 2 pm ET –
Registries continue to be a critical part of the real-world evidence equation, but over time they have become too trialized, too burdensome, and too separated from real clinical practice. Emerging methodologies, data digitization, and cognitive technologies have set the path for drastic changes needed to address these challenges and reveal the next generation of registries.
Join OM1’s CEO Dr. Richard Gliklich as he explores:
- The evolving role of big data in registries and real-world research
- Using advanced technology to access larger sample sizes, increase speed to data and provide broader insights
- Understand how this new approach to observational research and patient registries can deliver more representative evidence at a fraction of the current cost